non-paraneoplastic limbic encephalitis
ORPHA: 1639182 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Immunoglobulin Cold Chain | IV infusion 10% solution (100mg/mL), subcutaneous injection 20% solution | FDA Approved | 10 | 10d |
| rituximab Orphan Cold Chain | IV infusion 10mg/mL (100mg/10mL, 500mg/50mL vials) | FDA Approved | 11 | 14d |
Classification & Codes
Orphanet Code
ORPHA:163918non-paraneoplastic limbic encephalitis
| Orphanet | ORPHA:163918 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO